Framatome to produce Lu-177 at Romania’s Cernavoda

November 18, 2024, 9:30AMNuclear News
Bernard Fontana (left) of Framatome and Cosmin Ghiță of Nuclearelectrica. (Photo: Framatome)

Framatome and SN Nuclearelectrica, a partially state-owned Romanian nuclear energy company, have entered into a long-term cooperation agreement to produce the medical isotope lutetium-177 at Cernavoda nuclear power plant in Romania. Lu-177 is a beta-emitting radioisotope used in targeted radionuclide therapy for the treatment of neuroendocrine tumors and prostate cancer.

To continue reading, log in or create a free account!

Related Articles